In short
Brivaracetam, also known by its brand name Briviact, is an antiepileptic drug that has been the subject of numerous clinical trials. These studies aim to evaluate its efficacy, safety, and pharmacokinetics in treating various forms of epilepsy, particularly partial-onset seizures. The trials involve diverse patient populations, including adults, adolescents, and children, and explore different administration methods such as oral tablets, oral solutions, and intravenous injections.
At a glance
- Drug Name
- Brivaracetam (Briviact)
- Primary Use
- Treatment of partial-onset seizures in epilepsy
- Age Groups Studied
- 1 month to 75 years old
- Administration Methods
- Oral tablets, oral solutions, intravenous injections
- Key Outcome Measures
- Seizure frequency reduction, responder rates, safety/tolerability, pharmacokinetics
- Study Types
- Bioequivalence, long-term safety, efficacy, pharmacokinetics
- Special Populations
- Pediatric patients, Japanese subjects
- Treatment Approaches
- Adjunctive therapy, conversion to monotherapy
- Safety Assessments
- Adverse events, serious adverse events, tolerability
- Quality of Life Measures
- QOLIE-31-P, Hospital Anxiety and Depression Scale
What is Brivaracetam?
Brivaracetam is an antiepileptic drug (AED) used to treat epilepsy. It is also known by its brand name Briviact. Brivaracetam belongs to a class of medications called anticonvulsants, which are drugs designed to prevent or reduce the frequency of seizures in people with epilepsy.
Uses of Brivaracetam
Brivaracetam is primarily used to treat partial-onset seizures in patients with epilepsy. Partial-onset seizures, also known as focal seizures, are a type of epileptic seizure that starts in one area of the brain. These seizures can occur with or without secondary generalization, which means they may spread to involve both sides of the brain.
There are three main types of partial seizures that Brivaracetam can help with:
- Simple Partial Seizures: The person remains conscious but may experience unusual sensations or movements.
- Complex Partial Seizures: The person's consciousness is altered, and they may appear confused or perform repetitive movements.
- Partial Seizures evolving to Secondarily Generalized Seizures: The seizure starts in one area of the brain but then spreads to both sides, potentially causing a convulsion.
How Brivaracetam Works
While the exact mechanism of action is not fully understood, Brivaracetam is believed to work by binding to a protein in the brain called synaptic vesicle protein 2A (SV2A). This interaction is thought to help regulate the release of neurotransmitters (chemical messengers) in the brain, which may help to reduce abnormal electrical activity that causes seizures.
Forms and Administration
Brivaracetam is available in several forms to suit different patient needs:
- Oral tablets: Film-coated tablets in strengths of 10 mg, 25 mg, 50 mg, and 100 mg.
- Oral solution: A liquid form with a concentration of 10 mg/mL, which may be easier for some patients to swallow.
- Intravenous (IV) injection: A solution for injection with a concentration of 10 mg/mL, which can be used when oral administration is temporarily not feasible.
Brivaracetam is typically taken twice daily, in the morning and evening, with or without food. The dosage is usually adjusted based on the patient's age, weight, and response to treatment.
Efficacy and Safety
Clinical trials have shown that Brivaracetam is effective in reducing the frequency of partial-onset seizures in patients with epilepsy. In one study, patients taking Brivaracetam experienced a significant reduction in seizure frequency compared to those taking a placebo.
The safety profile of Brivaracetam has been evaluated in both short-term and long-term studies. These studies have shown that Brivaracetam is generally well-tolerated, with most side effects being mild to moderate in severity.
Side Effects
Like all medications, Brivaracetam can cause side effects. The most common side effects reported in clinical trials include:
- Drowsiness or sleepiness: This can affect your ability to drive or operate machinery.
- Dizziness: This may increase the risk of falls, especially in older adults.
- Nausea: Taking the medication with food may help reduce this side effect.
- Fatigue: You may feel more tired than usual.
- Headache: This is usually mild and may improve over time.
It's important to note that not everyone experiences these side effects, and they often improve as your body adjusts to the medication. Always report any persistent or severe side effects to your healthcare provider.
Special Populations
Brivaracetam has been studied in various age groups:
- Adults: Most studies have focused on adults aged 16 to 80 years old.
- Children and adolescents: Ongoing research is evaluating the safety and efficacy of Brivaracetam in patients from 1 month to 16 years of age.
- Elderly: Studies have included patients up to 80 years old, but caution is advised as older adults may be more sensitive to side effects.
The use of Brivaracetam during pregnancy and breastfeeding should be discussed with a healthcare provider, as the potential risks and benefits need to be carefully considered.
Ongoing Research
Several clinical trials are currently underway to further investigate the use of Brivaracetam:
- Long-term safety and efficacy studies in adults and children.
- Studies evaluating the use of Brivaracetam as monotherapy (used alone) for epilepsy.
- Research on the pharmacokinetics (how the body processes the drug) in different populations, including Chinese patients.
- Investigations into the use of intravenous Brivaracetam in situations where oral administration is not possible.
These ongoing studies aim to provide more information about the long-term use of Brivaracetam and its potential benefits in different patient groups.